{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T18:50:13Z","timestamp":1779130213013,"version":"3.51.4"},"reference-count":106,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.rdc.2011.09.009","type":"journal-article","created":{"date-parts":[[2011,10,26]],"date-time":"2011-10-26T02:48:35Z","timestamp":1319597315000},"page":"527-549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Rheumatic Manifestations of Primary and Metastatic Bone Tumors and Paraneoplastic Bone Disease"],"prefix":"10.1016","volume":"37","author":[{"given":"Christian A.","family":"Waimann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huifang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria E.","family":"Suarez Almazor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.rdc.2011.09.009_bib1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2106\/00004623-199903000-00003","article-title":"Delay in the diagnosis and treatment of primary bone sarcoma of the pelvis","volume":"81","author":"Wurtz","year":"1999","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"1","key":"10.1016\/j.rdc.2011.09.009_bib2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00002281-200301000-00012","article-title":"Musculoskeletal manifestations of benign and malignant tumors of bone","volume":"15","author":"Westhovens","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2011.09.009_bib3","series-title":"SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patient and Tumor Characteristics","first-page":"81","article-title":"Cancers of the Bone and Joint","author":"Lewis","year":"2007"},{"issue":"5","key":"10.1016\/j.rdc.2011.09.009_bib4","first-page":"277","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.rdc.2011.09.009_bib5","series-title":"SEER cancer statistics review, 1975-2008","author":"Howlader","year":"2011"},{"key":"10.1016\/j.rdc.2011.09.009_bib6","series-title":"Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995","first-page":"99","article-title":"Malignant Bone Tumors","author":"Gurney","year":"1999"},{"issue":"20 Pt 2","key":"10.1016\/j.rdc.2011.09.009_bib7","doi-asserted-by":"crossref","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","article-title":"Clinical features of metastatic bone disease and risk of skeletal morbidity","volume":"12","author":"Coleman","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.rdc.2011.09.009_bib8","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0360-3016(97)00106-5","article-title":"Localized primary malignant lymphoma of bone","volume":"37","author":"Dubey","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.rdc.2011.09.009_bib9","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1148\/radiology.137.3.7444049","article-title":"Hodgkin disease of bone: radiographic correlation with the histological classification","volume":"137","author":"Braunstein","year":"1980","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.rdc.2011.09.009_bib10","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s00247-010-1547-4","article-title":"Evaluation of pediatric bone lesions","volume":"40","author":"Wyers","year":"2010","journal-title":"Pediatr Radiol"},{"issue":"8","key":"10.1016\/j.rdc.2011.09.009_bib11","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1007\/s00330-003-1902-z","article-title":"Benign bone tumors and tumor-like lesions: value of cross-sectional imaging","volume":"13","author":"Woertler","year":"2003","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.rdc.2011.09.009_bib12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2106\/00004623-197557020-00007","article-title":"Giant-cell tumor of bone. A demographic, clinical, and histopathological study of all cases recorded in the Swedish Cancer Registry for the years 1958 through 1968","volume":"57","author":"Larsson","year":"1975","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"5","key":"10.1016\/j.rdc.2011.09.009_bib13","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2106\/00004623-198264050-00015","article-title":"Giant-cell tumor of bone: analysis of two hundred and eight cases in Chinese patients","volume":"64","author":"Sung","year":"1982","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"1","key":"10.1016\/j.rdc.2011.09.009_bib14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2106\/00004623-198769010-00018","article-title":"Giant-cell tumor of bone","volume":"69","author":"Campanacci","year":"1987","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"3","key":"10.1016\/j.rdc.2011.09.009_bib15","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s11999-009-0966-8","article-title":"Metastatic giant cell tumor of bone: are there associated factors and best treatment modalities?","volume":"468","author":"Viswanathan","year":"2010","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"10.1016\/j.rdc.2011.09.009_bib16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00008480-200302000-00010","article-title":"Benign bone tumors in children","volume":"15","author":"Yildiz","year":"2003","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.rdc.2011.09.009_bib17","series-title":"Pathology and genetics of tumours of soft tissue and bone","first-page":"227","article-title":"WHO classification of bone tumours","author":"Dorfman","year":"2006"},{"key":"10.1016\/j.rdc.2011.09.009_bib18","series-title":"Enfermedades reumaticas, cancer y sindromes reumaticos paraneoplasicos","author":"Niembro","year":"2007"},{"issue":"291","key":"10.1016\/j.rdc.2011.09.009_bib19","first-page":"229","article-title":"Osteoid osteoma diagnosis and management with low morbidity","author":"Ward","year":"1993","journal-title":"Clin Orthop Relat Res"},{"issue":"6","key":"10.1016\/j.rdc.2011.09.009_bib20","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1053\/sarh.2000.5752","article-title":"Incidence of occult cancer in children presenting with musculoskeletal symptoms: a 10-year survey in a pediatric rheumatology unit","volume":"29","author":"Trapani","year":"2000","journal-title":"Semin Arthritis Rheum"},{"issue":"Suppl 8","key":"10.1016\/j.rdc.2011.09.009_bib21","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G","article-title":"Skeletal complications of malignancy","volume":"80","author":"Coleman","year":"1997","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.rdc.2011.09.009_bib22","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/1097-0142(19891001)64:7<1548::AID-CNCR2820640733>3.0.CO;2-W","article-title":"Extraosseous Ewing\u2019s sarcoma. A study of 42 cases","volume":"64","author":"Rud","year":"1989","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.rdc.2011.09.009_bib23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.nec.2007.09.003","article-title":"Osteoid osteoma and osteoblastoma of the spine","volume":"19","author":"Kan","year":"2008","journal-title":"Neurosurg Clin N Am"},{"issue":"9","key":"10.1016\/j.rdc.2011.09.009_bib24","doi-asserted-by":"crossref","first-page":"863","DOI":"10.33588\/rn.2809.98474","volume":"28","author":"Perez-Martinez","year":"1999","journal-title":"Rev Neurol"},{"issue":"6","key":"10.1016\/j.rdc.2011.09.009_bib25","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00381-009-0873-z","article-title":"Ollier disease","volume":"25","author":"D\u2019Angelo","year":"2009","journal-title":"Childs Nerv Syst"},{"issue":"2","key":"10.1016\/j.rdc.2011.09.009_bib26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0889-8588(05)70509-8","article-title":"Langerhans cell histiocytosis in adults","volume":"12","author":"Malpas","year":"1998","journal-title":"Hematol Oncol Clin North Am"},{"issue":"Suppl 1","key":"10.1016\/j.rdc.2011.09.009_bib27","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.3949\/ccjm.77.s1.02","article-title":"Bone sarcomas: overview of management, with a focus on surgical treatment considerations","volume":"77","author":"Lietman","year":"2010","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.rdc.2011.09.009_bib28","first-page":"451","article-title":"Incidental bone lesions","volume":"51","author":"Rougraff","year":"2002","journal-title":"Instr Course Lect"},{"issue":"Suppl 1","key":"10.1016\/j.rdc.2011.09.009_bib29","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.3949\/ccjm.77.s1.01","article-title":"Clinical presentation and imaging of bone and soft-tissue sarcomas","volume":"77","author":"Ilaslan","year":"2010","journal-title":"Cleve Clin J Med"},{"issue":"3","key":"10.1016\/j.rdc.2011.09.009_bib30","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1148\/radiol.2463061038","article-title":"Bone tumors and tumorlike conditions: analysis with conventional radiography","volume":"246","author":"Miller","year":"2008","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.rdc.2011.09.009_bib31","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0033-8389(22)01351-3","article-title":"Radiologic and pathologic analysis of solitary bone lesions. Part I: internal margins","volume":"19","author":"Madewell","year":"1981","journal-title":"Radiol Clin North Am"},{"issue":"4","key":"10.1016\/j.rdc.2011.09.009_bib32","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0033-8389(22)01352-5","article-title":"Radiologic and pathologic analysis of solitary bone lesions. Part II: periosteal reactions","volume":"19","author":"Ragsdale","year":"1981","journal-title":"Radiol Clin North Am"},{"issue":"4","key":"10.1016\/j.rdc.2011.09.009_bib33","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nrendo.2010.227","article-title":"Bone metastasis: mechanisms and therapeutic opportunities","volume":"7","author":"Suva","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"10.1016\/j.rdc.2011.09.009_bib34","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0033-8389(22)01353-7","article-title":"Radiologic and pathologic analysis of solitary bone lesions. Part III: matrix patterns","volume":"19","author":"Sweet","year":"1981","journal-title":"Radiol Clin North Am"},{"issue":"8","key":"10.1016\/j.rdc.2011.09.009_bib35","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.rdc.2011.09.009_bib36","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1302\/0301-620X.74B4.1624505","article-title":"Epidemiological, clinical and radiological aspects of osteopoikilosis","volume":"74","author":"Benli","year":"1992","journal-title":"J\u00a0Bone Joint Surg Br"},{"issue":"2","key":"10.1016\/j.rdc.2011.09.009_bib37","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0033-8389(22)02866-4","article-title":"Two-dimensional and three-dimensional computed tomographic imaging in musculoskeletal tumors","volume":"31","author":"Magid","year":"1993","journal-title":"Radiol Clin North Am"},{"issue":"1","key":"10.1016\/j.rdc.2011.09.009_bib38","first-page":"27","article-title":"Bone scintigraphy and the added value of SPECT (single photon emission tomography) in detecting skeletal lesions","volume":"45","author":"Savelli","year":"2001","journal-title":"Q\u00a0J Nucl Med"},{"issue":"1","key":"10.1016\/j.rdc.2011.09.009_bib39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/(SICI)1097-0142(19990101)85:1<153::AID-CNCR21>3.0.CO;2-#","article-title":"Is there a diagnostic role for bone scanning of patients with a high pretest probability for metastatic renal cell carcinoma?","volume":"85","author":"Staudenherz","year":"1999","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.rdc.2011.09.009_bib40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2141.2007.06491.x","article-title":"Guidelines for the use of imaging in the management of myeloma","volume":"137","author":"D\u2019Sa","year":"2007","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.rdc.2011.09.009_bib41","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.crad.2010.07.002","article-title":"Comparative study of whole-body MRI and bone scintigraphy for the detection of bone metastases","volume":"65","author":"Balliu","year":"2010","journal-title":"Clin Radiol"},{"issue":"4","key":"10.1016\/j.rdc.2011.09.009_bib42","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1053\/j.semnuclmed.2006.05.001","article-title":"The role of single-photon emission computed tomography\/computed tomography in benign and malignant bone disease","volume":"36","author":"Horger","year":"2006","journal-title":"Semin Nucl Med"},{"issue":"5","key":"10.1016\/j.rdc.2011.09.009_bib43","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00776-007-1152-z","article-title":"Secondary chondrosarcoma in cartilage bone tumors: report of 32 patients","volume":"12","author":"Altay","year":"2007","journal-title":"J\u00a0Orthop Sci"},{"issue":"2","key":"10.1016\/j.rdc.2011.09.009_bib44","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2106\/00004623-198769020-00016","article-title":"The malignant potential of enchondromatosis","volume":"69","author":"Schwartz","year":"1987","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"3","key":"10.1016\/j.rdc.2011.09.009_bib45","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1056\/NEJM200001203420306","article-title":"The physiology of parathyroid hormone-related protein","volume":"342","author":"Strewler","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.rdc.2011.09.009_bib46","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJM199004193221603","article-title":"Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer","volume":"322","author":"Burtis","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.rdc.2011.09.009_bib47","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1677\/erc.1.00543","article-title":"Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone","volume":"12","author":"Clines","year":"2005","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"10.1016\/j.rdc.2011.09.009_bib48","first-page":"607","article-title":"Differences in bone and vitamin D metabolism between primary hyperparathyroidism and malignancy-associated hypercalcemia","volume":"81","author":"Nakayama","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.rdc.2011.09.009_bib49","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJMcp042806","article-title":"Clinical practice. Hypercalcemia associated with cancer","volume":"352","author":"Stewart","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.rdc.2011.09.009_bib50","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1385\/ENDO:27:1:083","article-title":"Parathyroid hormone expression in a patient with metastatic nasopharyngeal rhabdomyosarcoma and hypercalcemia","volume":"27","author":"Wong","year":"2005","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.rdc.2011.09.009_bib51","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jama.286.3.341","article-title":"The rational clinical examination. Does this patient have clubbing?","volume":"286","author":"Myers","year":"2001","journal-title":"JAMA"},{"issue":"7088","key":"10.1016\/j.rdc.2011.09.009_bib52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(59)92109-9","article-title":"Instrument for estimation of clubbing","volume":"2","author":"Stavem","year":"1959","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.rdc.2011.09.009_bib53","first-page":"297","article-title":"Personal experience","volume":"50","author":"Schamroth","year":"1976","journal-title":"S\u00a0Afr Med J"},{"issue":"3","key":"10.1016\/j.rdc.2011.09.009_bib54","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1053\/berh.2000.0091","article-title":"Paraneoplastic rheumatic syndromes","volume":"14","author":"Fam","year":"2000","journal-title":"Baillieres Best Pract Res Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2011.09.009_bib55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10067-010-1563-7","article-title":"Review of current therapies for secondary hypertrophic pulmonary osteoarthropathy","volume":"30","author":"Nguyen","year":"2011","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2011.09.009_bib56","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00002281-199701000-00016","article-title":"Hypertrophic osteoarthropathy","volume":"9","author":"Martinez-Lavin","year":"1997","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2011.09.009_bib57","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/ng.153","article-title":"Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy","volume":"40","author":"Uppal","year":"2008","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.rdc.2011.09.009_bib58","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1378\/chest.114.6.1535","article-title":"Digital clubbing and lung cancer","volume":"114","author":"Sridhar","year":"1998","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.rdc.2011.09.009_bib59","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/JTO.0b013e3181dc1f3c","article-title":"Hypertrophic pulmonary osteoarthropathy as a paraneoplastic manifestation of lung cancer","volume":"5","author":"Ito","year":"2010","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.rdc.2011.09.009_bib60","series-title":"Medical care of cancer patients","first-page":"194","article-title":"Endocrine paraneoplastic syndromes","author":"Hu","year":"2009"},{"issue":"3","key":"10.1016\/j.rdc.2011.09.009_bib61","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-11-0006","article-title":"Tumor-induced osteomalacia","volume":"18","author":"Chong","year":"2011","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"10.1016\/j.rdc.2011.09.009_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","article-title":"Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature","volume":"28","author":"Folpe","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"4-5","key":"10.1016\/j.rdc.2011.09.009_bib63","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/01913129109016242","article-title":"Review and update: oncogenic osteomalacia-rickets","volume":"15","author":"Weidner","year":"1991","journal-title":"Ultrastruct Pathol"},{"issue":"10","key":"10.1016\/j.rdc.2011.09.009_bib64","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/jbmr.170","article-title":"FGF-23: more than a regulator of renal phosphate handling?","volume":"25","author":"Juppner","year":"2010","journal-title":"J\u00a0Bone Miner Res"},{"issue":"5","key":"10.1016\/j.rdc.2011.09.009_bib65","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1586\/eem.09.27","article-title":"Tumor-induced osteomalacia","volume":"4","author":"Farrow","year":"2009","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"17","key":"10.1016\/j.rdc.2011.09.009_bib66","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMe030037","article-title":"Oncogenic osteomalacia\u2014a complex dance of factors","volume":"348","author":"Carpenter","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.rdc.2011.09.009_bib67","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/ncpendmet0639","article-title":"Tumor-induced osteomalacia: the importance of measuring serum phosphorus levels","volume":"3","author":"Halperin","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.rdc.2011.09.009_bib68","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/jbmr.316","article-title":"Selective venous catheterization for the localization of phosphaturic mesenchymal tumors","volume":"26","author":"Andreopoulou","year":"2011","journal-title":"J\u00a0Bone Miner Res"},{"issue":"3","key":"10.1016\/j.rdc.2011.09.009_bib69","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11926-010-0098-x","article-title":"Cancer therapies and bone health","volume":"12","author":"Hu","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.rdc.2011.09.009_bib70","series-title":"SEER cancer statistics review, 1975\u20132007","author":"Altekruse","year":"2010"},{"issue":"2","key":"10.1016\/j.rdc.2011.09.009_bib71","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11764-009-0083-4","article-title":"Skeletal sequelae of cancer and cancer treatment","volume":"3","author":"Stava","year":"2009","journal-title":"J\u00a0Cancer Surviv"},{"issue":"2","key":"10.1016\/j.rdc.2011.09.009_bib72","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2174\/156652411794859223","article-title":"Pathobiology and prevention of cancer chemotherapy-induced bone growth arrest, bone loss, and osteonecrosis","volume":"11","author":"Fan","year":"2011","journal-title":"Curr Mol Med"},{"issue":"5","key":"10.1016\/j.rdc.2011.09.009_bib73","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/archinte.165.5.552","article-title":"Fracture risk among breast cancer survivors: results from the Women\u2019s Health Initiative Observational Study","volume":"165","author":"Chen","year":"2005","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.rdc.2011.09.009_bib74","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1210\/jcem.87.8.8782","article-title":"Bone loss following hypogonadism in men with prostate cancer treated with GnRH analogs","volume":"87","author":"Mittan","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.rdc.2011.09.009_bib75","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/bcr2818","article-title":"Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management","volume":"13","author":"Gaillard","year":"2011","journal-title":"Breast Cancer Res"},{"issue":"9484","key":"10.1016\/j.rdc.2011.09.009_bib76","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(05)67059-6","article-title":"Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years\u2019 adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial","volume":"366","author":"Jakesz","year":"2005","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.rdc.2011.09.009_bib77","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/jnci\/djm246","article-title":"Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a","volume":"99","author":"Jakesz","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"8","key":"10.1016\/j.rdc.2011.09.009_bib78","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1470-2045(06)70767-7","article-title":"Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial (Arimidex Tamoxifen Alone or in Combination Trialists\u2019 Group)","volume":"7","author":"Buzdar","year":"2006","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.rdc.2011.09.009_bib79","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1470-2045(07)70385-6","article-title":"Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial (Arimidex Tamoxifen Alone or in Combination Trialists\u2019 Group)","volume":"9","author":"Forbes","year":"2008","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.rdc.2011.09.009_bib80","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1200\/JCO.2006.08.8617","article-title":"Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98","volume":"25","author":"Coates","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"9561","key":"10.1016\/j.rdc.2011.09.009_bib81","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0140-6736(07)60200-1","article-title":"Survival and safety of exemestane versus tamoxifen after 2-3 years\u2019 tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial","volume":"369","author":"Coombes","year":"2007","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.rdc.2011.09.009_bib82","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/jnci\/dji250","article-title":"Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17","volume":"97","author":"Goss","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.rdc.2011.09.009_bib83","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1200\/JCO.2005.02.3515","article-title":"Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status","volume":"24","author":"Vehmanen","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.rdc.2011.09.009_bib84","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1210\/en.2006-0459","article-title":"Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density","volume":"147","author":"Jia","year":"2006","journal-title":"Endocrinology"},{"issue":"Suppl 1","key":"10.1016\/j.rdc.2011.09.009_bib85","first-page":"33","article-title":"Mechanisms of steroid impairment of growth","volume":"58","author":"Hochberg","year":"2002","journal-title":"Horm Res"},{"issue":"5","key":"10.1016\/j.rdc.2011.09.009_bib86","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0360-3016(92)90895-O","article-title":"Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer","volume":"23","author":"Pierce","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.rdc.2011.09.009_bib87","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ijrobp.2009.05.059","article-title":"Insufficiency fractures after pelvic radiotherapy in patients with prostate cancer","volume":"77","author":"Igdem","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.rdc.2011.09.009_bib88","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ncpneph0124","article-title":"Hypophosphatemia: an evidence-based approach to its clinical consequences and management","volume":"2","author":"Amanzadeh","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"issue":"2 Pt 1","key":"10.1016\/j.rdc.2011.09.009_bib89","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0022-3476(05)80557-8","article-title":"Ifosfamide-induced renal tubular dysfunction and rickets in children with Wilms tumor","volume":"117","author":"Burk","year":"1990","journal-title":"J\u00a0Pediatr"},{"issue":"18","key":"10.1016\/j.rdc.2011.09.009_bib90","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1001\/jama.293.18.2257","article-title":"Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials","volume":"293","author":"Bischoff-Ferrari","year":"2005","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.rdc.2011.09.009_bib91","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.rdc.2011.09.009_bib92","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1524-4741.2010.01012.x","article-title":"High prevalence of low vitamin D and musculoskeletal complaints in women with breast cancer","volume":"16","author":"Napoli","year":"2010","journal-title":"Breast J"},{"issue":"3","key":"10.1016\/j.rdc.2011.09.009_bib93","first-page":"139","article-title":"Aging and osteoporosis in breast and prostate cancer","volume":"61","author":"VanderWalde","year":"2011","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 3","key":"10.1016\/j.rdc.2011.09.009_bib94","first-page":"S1","article-title":"NCCN Task Force Report: bone health in cancer care","volume":"7","author":"Gralow","year":"2009","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"4","key":"10.1016\/j.rdc.2011.09.009_bib95","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00198-009-1003-1","article-title":"The epidemiology of osteonecrosis: findings from the GPRD and THIN databases in the UK","volume":"21","author":"Cooper","year":"2010","journal-title":"Osteoporos Int"},{"issue":"7","key":"10.1016\/j.rdc.2011.09.009_bib96","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1097\/01.TP.0000138026.40907.38","article-title":"Avascular osteonecrosis after allogeneic hematopoietic stem-cell transplantation: diagnosis and gender matter","volume":"78","author":"Schulte","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.rdc.2011.09.009_bib97","article-title":"Clinico-therapeutic management of osteoradionecrosis: a literature review and update","author":"Silvestre-Rangil","year":"2011","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"1","key":"10.1016\/j.rdc.2011.09.009_bib98","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S8756-3282(97)00219-6","article-title":"Avascular necrosis following bone marrow transplantation: a case-control study","volume":"22","author":"Fink","year":"1998","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.rdc.2011.09.009_bib99","first-page":"1099","article-title":"A\u00a0systematic review of bisphosphonate osteonecrosis (BON) in cancer","volume":"18","author":"Migliorati","year":"2010","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.rdc.2011.09.009_bib100","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10549-010-0866-3","article-title":"Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer","volume":"122","author":"Guarneri","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"18","key":"10.1016\/j.rdc.2011.09.009_bib101","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1002\/cncr.24474","article-title":"Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation","volume":"115","author":"Campbell","year":"2009","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.rdc.2011.09.009_bib102","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/ncponc0688","article-title":"Therapy insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease","volume":"4","author":"Dunstan","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"issue":"1","key":"10.1016\/j.rdc.2011.09.009_bib103","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrendo.2010.195","article-title":"Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review","volume":"7","author":"Migliorati","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10.1016\/j.rdc.2011.09.009_bib104","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1747-4477.2009.00213.x","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw\u2014 2009 update","volume":"35","author":"Ruggiero","year":"2009","journal-title":"Aust Endod J"},{"issue":"34","key":"10.1016\/j.rdc.2011.09.009_bib105","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors","volume":"23","author":"Bamias","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.rdc.2011.09.009_bib106","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000201931","article-title":"Combination of bisphosphonates and antiangiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates alone","volume":"76","author":"Christodoulou","year":"2009","journal-title":"Oncology"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X11000640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X11000640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:10:11Z","timestamp":1760181011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X11000640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":106,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0889857X11000640"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2011.09.009","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rheumatic Manifestations of Primary and Metastatic Bone Tumors and Paraneoplastic Bone Disease","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2011.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}